The Sterile Product Development (SPD) group develops non-oral dosage forms—including injections, implants, inhaled products, and ocular products—for small, intermediate, and large molecules, from preclinical toxicology through commercialization. The group develops formulation, primary packaging and device, process, and manufacturing strategies using scientific understanding and characterization, experimental design, analytical tools, and predictive approaches to support scalable development while maintaining stability, safety, efficacy, and delivery. The Principal Scientist will serve as an Early-Stage Development and Commercialization Team (DCT) Leader for assigned pipeline biologics. The role provides strategic, technical, and operational direction to integrated CMC teams, advancing programs from candidate selection through early clinical development and First-in-Human milestones while preparing for commercialization. The position requires biologics product development experience, continued support of relevant drug product activities, broad working knowledge of end-to-end CMC disciplines, and the ability to lead matrixed teams with a focus on robustness at launch. The role is based at the research facility in Rahway, New Jersey. The position is regular status, offers domestic or international relocation, visa sponsorship, and requires 10% travel. The employee is eligible for an annual bonus and long-term incentive, if applicable. The stated salary range for the primary location is $173,200 to $272,600.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Principal
Education Level
Ph.D. or professional degree